deltatrials

Rheumatoid arthritis Trials in Mérida, Mexico

Conditions / Rheumatoid arthritis / Mérida, Mexico

Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.

45 total trials for this combination

Showing top 10 of 45 trials

Trials

NCT ID Title Status Phase
NCT02629159 A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate ACTIVE_NOT_RECRUITING PHASE3
NCT01194414 A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis COMPLETED PHASE3
NCT01061736 Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients COMPLETED PHASE2/PHASE3
NCT01331837 A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors COMPLETED PHASE4
NCT03025308 Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis COMPLETED PHASE3
NCT01146652 Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) COMPLETED PHASE3
NCT01519791 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis COMPLETED PHASE3
NCT01885078 An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis COMPLETED PHASE3
NCT01521923 A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis COMPLETED PHASE3
NCT01710358 A Study in Moderate to Severe Rheumatoid Arthritis COMPLETED PHASE3

Related Pages